Search Results for "rapid"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for rapid. Results 161 to 170 of 541 total matches.
Pharmacogenetic-Based Dosing of Warfarin
The Medical Letter on Drugs and Therapeutics • May 19, 2008 (Issue 1286)
SNPs. A rapid turnaround (1 hour) assay allowed
determination of genotype and dose selection before ...
Warfarin sodium (Coumadin, and others) and other coumarin anticoagulants prevent thrombosis, but patient response is highly variable and overanticoagulation can lead to hemorrhage. Genotyping patients for single nucleotide polymorphisms (SNPs) that affect coumarin metabolism and sensitivity may help clinicians estimate the therapeutic warfarin dose. The FDA has added a note to warfarin labeling recommending lowrange doses for patients with such genetic variations. Commercial tests for these variants are now available and cost about $500 per test.
Colorectal Cancer Screening
The Medical Letter on Drugs and Therapeutics • Jul 01, 2019 (Issue 1575)
used routinely, they may detect rapidly growing cancers.
Their usefulness is limited ...
Most colorectal cancers arise from localized
adenomatous polyps in a process that may take
10 years or more. Early detection and removal of
a precancerous colonic lesion (polyp) can prevent
cancer from developing.
Surfactant for Premature Infants With Respiratory Distress
The Medical Letter on Drugs and Therapeutics • Jan 12, 1990 (Issue 809)
randomized trial, however, also using a single post-ventilatory dose, found rapid improvement in
oxygenation ...
The US Food and Drug Administration recently approved ''Treatment IND';'; (investigational new drug) protocols for Exosurf (Burroughs Wellcome) and Survanta (Ross), two preparations of surfactant used for prevention and treatment of the respiratory distress syndrome (RDS) in premature newborn infants. Consequently, these drugs will be available to virtually every level-ΙΙΙ neonatal intensive-care unit in the USA.
Pegademase
The Medical Letter on Drugs and Therapeutics • Sep 21, 1990 (Issue 827)
infections. Given alone, the enzyme is eliminated too rapidly to be helpful, but covalent attachment of
PEG ...
Pegademase (Adagen - Enzon), bovine adenosine deaminase (ADA) conjugated with polyethylene glycol (PEG), was recently approved by the US Food and Drug Administration as an 'orphan drug' for treatment of severe combined immunodeficiency disease (SCID). SCID due to inherited deficiency of ADA occurs in less than one per million births; until recently, without extraordinary isolation measures, it was usually fatal before the age of two.
Isradipine For Hypertension
The Medical Letter on Drugs and Therapeutics • May 31, 1991 (Issue 845)
PHARMACOLOGY — Isradipine is rapidly absorbed from the gastrointestinal tract and undergoes extensive first ...
Isradipine (DynaCirc - Sandoz), a dihydropyridine calcium-channel blocker chemically related to nicardipine (Cardene) and nifedipine (Procardia, and others), was recently approved by the US Food and Drug Administration for oral treatment of hypertension.
LAAM - Long-Acting Methadone for Treatment of Heroin Addiction
The Medical Letter on Drugs and Therapeutics • Jun 10, 1994 (Issue 924)
in treatment for many
years with no adverse effects.
PHARMACOKINETICS — LAAM is rapidly absorbed ...
Methadone, an opioid agonist that can be taken orally, has been used for maintenance treatment for many years in the USA (DM Novick et al, Drug Alcohol Depend, 33:235, 1993). Last year, the US Food and Drug Administration approved the distribution and use of L-alpha-acetyl-methadol (LAAM; ORLAAM - Bio Development Corporation, McLean, VA), a long-acting congener of methadone. LAAM, like methadone, will be available for this indication only through federal and state-regulated treatment programs.
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter on Drugs and Therapeutics • Jun 06, 1997 (Issue 1002)
.
PHARMACOKINETICS — Donepezil is rapidly absorbed from the gastrointestinal tract, reaching peak plasma ...
Donepezil hydrochloride (Aricept - Eisai), a piperidine-based acetylcholinesterase inhibitor, is now being marketed for oral treatment of cognitive symptoms in patients with mild to moderate dementia due to Alzheimer's disease. Donepezil is the second drug approved for this indication; tacrine hydrochloride (Cognex), also an acetylcholinesterase inhibitor, has been available in the USA for four years (Medical Letter, 35:87, 1993).
Electronic Cigarettes
The Medical Letter on Drugs and Therapeutics • Nov 11, 2013 (Issue 1429)
and possibly
cardiovascular toxicity. o
1. CK Yamin. E-cigarettes: a rapidly growing Internet phenomenon ...
Electronic cigarettes, also called e-cigarettes, are advertised
as a safer, more convenient, and socially acceptable
alternative to smoking tobacco cigarettes. Widely
available in retail stores and on the Internet, their use
has been increasing over recent years, primarily among
smokers, but also among non-smokers.
Clarification: Half-Life of Heroin
The Medical Letter on Drugs and Therapeutics • Feb 29, 2016 (Issue 1489)
is
correct, but heroin is a prodrug that is rapidly metabolized
to 6-acetylmorphine and morphine. The risk ...
A reader expressed concern that a statement in our article Naloxone (Narcan) Nasal Spray for Opioid Overdose (Med Lett Drugs Ther 2016; 58:1) might be misleading. We stated that heroin has a half-life of 2-6 minutes, which is correct, but heroin is a prodrug that is rapidly metabolized to 6-acetylmorphine and morphine. The risk of respiratory depression is related to those active metabolites, and it may persist well beyond the clearance of heroin from the blood.
Drug Interaction: Opioids and Oral P2Y12 Platelet Inhibitors
The Medical Letter on Drugs and Therapeutics • Feb 25, 2019 (Issue 1566)
of acute coronary syndrome
(ACS). Rapid onset of antiplatelet activity is desired to
prevent occlusive ...
The FDA has required manufacturers of the oral P2Y12
platelet inhibitors clopidogrel (Plavix, and generics),
prasugrel (Effient, and generics), and ticagrelor
(Brilinta) to warn in the product labels that the
absorption of these drugs may be delayed or reduced
when taken with an opioid agonist.